検索結果

发表论文 | 研究与开发 | 千寿制药株式会社

576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132...

NewMytear CL Cool-s | OTC Products, etc. | Products | SENJU Pharmaceutical

TIONS FOR USE Who should seek consultation 1. The following persons should consult a physician, pharmacist, or registered salesperson** before using this medicine: Persons under treatment by a physici...

学会发表 | 研究与开发 | 千寿制药株式会社

ndo, FL, USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunor...

せ先 □ ■ □ 「マイティアブランド CM『ひろがれ、瞳のチカラ。』スピンオフムービー」 PR 事務局（株式会社マテリアル） TEL：03-5459-5490 FAX：03-5459-5491 E-mail：osaka@materialpr.jp 担当：廣瀬（090-3611-1503） / 三木（070-3874-4269） リリース内画像素材：https://bit.ly/3UnUTMV 素...

OTC Products, etc. | Products | SENJU Pharmaceutical

Inquiries are not accepted in a language other than Japanese in principle. Please kindly understand the situation that the inquiries by telephone must use Japanese only. Translated from the Japanese p